Ascendis Pharma A (ASND) Non-Current Assets (2012 - 2026)
Ascendis Pharma A's Non-Current Assets was $1.04 billion in the quarter ended Jun 30, 2026, up 581.5% from $152.75 million a year earlier and up 0.9% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Non-Current Assets (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, Non-Current Assets at Ascendis Pharma A came in at $218.71 million, down 89.9% from the prior year.
- Non-Current Assets shows a five-year compound annual growth rate of 61.6% (years ended Dec 2020 to Dec 2025).
- In earlier years, Non-Current Assets was $2.16 billion in the year ended Dec 31, 2024, $132.91 million in the year ended Dec 31, 2023 (-24.2%), $175.24 million in the year ended Dec 31, 2022 (-86.3%) and $1.28 billion in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Non-Current Assets since the quarter ended Dec 31, 2024.
- Compared with a year earlier, Non-Current Assets was higher in four of the last seven quarters, with growth averaging 158.1%.
- The best year-over-year quarter for Non-Current Assets over five years was the quarter ended Mar 31, 2026 (growth of 600.6%); the worst was the quarter ended Dec 31, 2025 (a decline of 89.4%).
- Per Business Quant data, ASND's Non-Current Assets in the three quarters before the quarter ended Jun 30, 2026 was $1.03 billion (quarter ended Mar 31, 2026), $225.34 million (quarter ended Dec 31, 2025) and $160.12 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Ascendis Pharma A | 14.26 Bn | 10.50 Bn | 362.22 Mn | 1.04 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Bn |
| Mar 31, 2026 | 1.03 Bn |
| Dec 31, 2025 | 225.34 Mn |
| Sep 30, 2025 | 160.12 Mn |
| Jun 30, 2025 | 152.75 Mn |
| Mar 31, 2025 | 147.21 Mn |
| Dec 31, 2024 | 2.13 Bn |
| Sep 30, 2024 | 131.83 Mn |
| Jun 30, 2024 | 141.05 Mn |
| Mar 31, 2024 | 150.34 Mn |
| Dec 31, 2023 | 132.20 Mn |
| Sep 30, 2023 | 152.72 Mn |
| Jun 30, 2023 | 159.14 Mn |
| Mar 31, 2023 | 167.90 Mn |
| Dec 31, 2022 | 169.63 Mn |
| Sep 30, 2022 | 195.12 Mn |
| Jun 30, 2022 | 229.14 Mn |
| Mar 31, 2022 | 287.51 Mn |
| Dec 31, 2021 | 1.28 Bn |
| Sep 30, 2021 | 293.22 Mn |
API Access
Ascendis Pharma A Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();